 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 1271 - 1280 of 2187:
FDA to review tattoo chemicals
Prompted by reports of skin problems, including rashes, swelling and blistering, the federal government has begun studying materials tattoo artists ha...
FDA to Review TNF Blockers for Link to Cancer in Youths
The U.S. Food and Drug Administration on Wednesday announced a safety review of several drugs known as tumor necrosis factors, or TNF blockers, as the...
FDA to review Watson's longer-lasting cancer drug
Watson Pharmaceuticals said federal health officials should make a decision on a long-lasting version of its prostate cancer drug Trelstar by third qu...
FDA to Revise Rules For Cold Medications Meant for Children
The Food and Drug Administration yesterday announced plans to revise standards for over-the-counter cough and cold medications for children, a step th...
FDA to rule on GTx Inc. drug Oct. 30
The U.S. Food and Drug Administration will decide on GTx Inc.’s new drug application on Oct. 30. The FDA received the Memphis pharmaceutical company’...
FDA to Seek More Safety Data on Stents
The Food and Drug Administration on Wednesday laid out new guidelines for the testing of drug-coated stents, more than two years after safety concerns...
FDA to seek panel's advice on LASIK
The U.S. Food and Drug Administration plans to seek advice from a panel of outside experts over whether to provide more information to patients about ...
FDA To Seek Strong Warnings For 11 Epilepsy Drugs
The U.S. Food and Drug Administration will seek to include strong warnings about suicidal behavior on labels of 11 epilepsy drugs, according to docume...
FDA to Speed Ligand, Glaxo Application
Drug developers Ligand Pharmaceuticals Inc. and GlaxoSmithKline PLC said Monday the Food and Drug Administration will give their blood-disorder drug P...
FDA to speed review of generic applications
The U.S. Food and Drug Administration approved one-third more generic drugs last fiscal year and said it planned to speed review of these cheaper vers... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |